Leap Therapeutics Inc
NASDAQ:LPTX
Income Statement
Earnings Waterfall
Leap Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-87m
USD
|
Operating Income
|
-87m
USD
|
Other Expenses
|
5.6m
USD
|
Net Income
|
-81.4m
USD
|
Income Statement
Leap Therapeutics Inc
Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+100%
|
1
+50%
|
2
+32%
|
2
+1%
|
2
N/A
|
2
N/A
|
2
-1%
|
1
-24%
|
1
-33%
|
0
-50%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||
Operating Expenses |
(28)
|
(25)
|
(32)
|
(34)
|
(32)
|
(28)
|
(28)
|
(28)
|
(31)
|
(33)
|
(35)
|
(34)
|
(33)
|
(31)
|
(31)
|
(31)
|
(30)
|
(33)
|
(35)
|
(40)
|
(43)
|
(44)
|
(51)
|
(54)
|
(57)
|
(59)
|
(87)
|
(86)
|
(87)
|
|
Selling, General & Administrative |
(4)
|
(6)
|
(8)
|
(9)
|
(10)
|
(8)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
(12)
|
(12)
|
(13)
|
(13)
|
(14)
|
(14)
|
|
Research & Development |
(23)
|
(19)
|
(24)
|
(26)
|
(23)
|
(20)
|
(20)
|
(19)
|
(22)
|
(24)
|
(26)
|
(26)
|
(24)
|
(22)
|
(21)
|
(21)
|
(20)
|
(23)
|
(24)
|
(29)
|
(32)
|
(33)
|
(40)
|
(42)
|
(45)
|
(47)
|
(44)
|
(43)
|
(73)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(30)
|
(30)
|
0
|
|
Operating Income |
(28)
N/A
|
(25)
+8%
|
(32)
-28%
|
(34)
-5%
|
(32)
+5%
|
(28)
+12%
|
(28)
+1%
|
(28)
0%
|
(31)
-9%
|
(33)
-8%
|
(35)
-5%
|
(34)
+2%
|
(33)
+2%
|
(31)
+7%
|
(30)
+3%
|
(30)
+1%
|
(29)
+4%
|
(31)
-10%
|
(33)
-7%
|
(38)
-14%
|
(41)
-9%
|
(43)
-4%
|
(50)
-17%
|
(53)
-6%
|
(57)
-6%
|
(59)
-4%
|
(87)
-46%
|
(86)
+1%
|
(87)
-1%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(0)
|
(1)
|
0
|
1
|
(5)
|
(5)
|
(4)
|
7
|
12
|
13
|
11
|
0
|
(1)
|
0
|
1
|
1
|
2
|
1
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
0
|
1
|
2
|
3
|
4
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(30)
|
0
|
0
|
0
|
|
Total Other Income |
3
|
4
|
4
|
5
|
2
|
2
|
2
|
1
|
1
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
1
|
2
|
2
|
2
|
2
|
2
|
|
Pre-Tax Income |
(26)
N/A
|
(22)
+13%
|
(29)
-31%
|
(29)
+2%
|
(30)
-3%
|
(31)
-4%
|
(32)
-1%
|
(31)
+1%
|
(23)
+26%
|
(21)
+9%
|
(22)
-5%
|
(23)
-6%
|
(33)
-41%
|
(32)
+4%
|
(30)
+6%
|
(29)
+3%
|
(28)
+4%
|
(29)
-7%
|
(32)
-10%
|
(37)
-13%
|
(41)
-11%
|
(42)
-3%
|
(49)
-18%
|
(53)
-8%
|
(54)
-2%
|
(86)
-58%
|
(82)
+4%
|
(81)
+2%
|
(81)
-1%
|
|
Net Income | ||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(26)
|
(22)
|
(29)
|
(29)
|
(41)
|
(42)
|
(43)
|
(43)
|
(23)
|
(21)
|
(22)
|
(23)
|
(33)
|
(32)
|
(30)
|
(29)
|
(28)
|
(29)
|
(32)
|
(37)
|
(41)
|
(42)
|
(49)
|
(53)
|
(55)
|
(86)
|
(82)
|
(81)
|
(81)
|
|
Net Income (Common) |
(26)
N/A
|
(23)
+12%
|
(30)
-30%
|
(29)
+2%
|
(30)
-3%
|
(31)
-3%
|
(31)
-1%
|
(31)
+1%
|
(23)
+26%
|
(21)
+7%
|
(22)
-5%
|
(24)
-6%
|
(33)
-40%
|
(42)
-25%
|
(40)
+4%
|
(39)
+2%
|
(38)
+3%
|
(29)
+22%
|
(32)
-10%
|
(37)
-13%
|
(41)
-11%
|
(42)
-3%
|
(49)
-18%
|
(53)
-8%
|
(55)
-2%
|
(86)
-58%
|
(82)
+4%
|
(81)
+2%
|
(81)
0%
|
|
EPS (Diluted) |
-27.27
N/A
|
-32.85
-20%
|
-31.46
+4%
|
-30.97
+2%
|
-32.57
-5%
|
-24.95
+23%
|
-21.35
+14%
|
-21.22
+1%
|
-16.41
+23%
|
-11.18
+32%
|
-9.81
+12%
|
-9.95
-1%
|
-14.73
-48%
|
-13.17
+11%
|
-7.58
+42%
|
-5.09
+33%
|
-6.34
-25%
|
-4.92
+22%
|
-5.43
-10%
|
-4.66
+14%
|
-4.73
-2%
|
-4.73
N/A
|
-5.58
-18%
|
-4.7
+16%
|
-4.82
-3%
|
-6.65
-38%
|
-5.6
+16%
|
-3
+46%
|
-3.98
-33%
|